CAS 502139-01-7

Synucleozid

CAS : 502139-01-7

Synucleozid is an anticancer drug that has shown promising results in the treatment of tumors. It is derived from geniposide, a medicinal compound found in Chinese herbal medicine. Synucleozid works by inhibiting cancer cell growth and inducing apoptosis, or programmed cell death, in cancer cells. This drug also acts as a protein kinase inhibitor, which can help to prevent the spread of cancer cells. Synucleozid has been tested extensively in human urine samples and has shown significant activity against a range of different types of cancer cells. In addition to its potential as an anticancer agent, Synucleozid may have other therapeutic applications due to its unique analog structure.

Formule : C₂₂H₂₁ClN₆

Degré de pureté : Min. 95%

Masse moléculaire : 404.9 g/mol

Ref: 3D-CVA13901

Synucleozid

CAS : 502139-01-7

Synucleozid is a potent the SNCA mRNA inhibitor that encodes α-synuclein protein (IC50=1.5 μM), has the potential for the investigation of Parkinson’s disease.

Formule : C₂₂H₂₀N₆

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 368.43

Ref: TM-T13049